ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV (Nasdaq: ARYD) is a healthcare-focused blank-check company sponsored by ARYA Sciences Holdings IV LLC, an affiliate of Perceptive Advisors, a life sciences-oriented investment firm. The company completed its initial public offering in 2021, targeting business combinations in the life sciences and biopharmaceutical sector. ARYD filed a Form 10-Q with the Securities and Exchange Commission on November 7, 2022, reflecting the company's status during its search for a qualifying merger target. The ARYA Sciences franchise has been among the more active life sciences SPAC sponsors, deploying multiple vehicles under the Perceptive Advisors umbrella. Sign up at SpacDesk for complete filing histories, deal timelines, and SPAC analytics on ARYD and the broader ARYA Sciences franchise.